Stay updated on Faricimab in Diabetic Macular Edema Clinical Trial
Sign up to get notified when there's something new on the Faricimab in Diabetic Macular Edema Clinical Trial page.

Latest updates to the Faricimab in Diabetic Macular Edema Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedAdded Revision: v3.4.2 and removed Revision: v3.4.1 from the site’s revision history.SummaryDifference0.0%

- Check17 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1 and appears to be a non-substantive change to page metadata with no observed changes to study content; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check31 days agoChange DetectedAdded a new publication citation for the RHONE-X extension trial (Four-Year Outcomes of Faricimab in Diabetic Macular Edema). The page metadata was updated to include Last Update Submitted that Met QC Criteria, No FEAR Act Data, and Revision: v3.4.0.SummaryDifference0.1%

- Check38 days agoChange DetectedRevision tag updated to v3.3.4 (replacing v3.3.3); no visible changes to the Study Details page content or its functionality.SummaryDifference0.0%

- Check66 days agoChange DetectedLocations section updated with new study sites across multiple countries (US states, Australia, Brazil, Canada, Italy, Russia, Spain) and a revision tag.SummaryDifference2%

- Check88 days agoChange DetectedPage revision updated from v3.3.1 to v3.3.2. No observable changes to trial details, eligibility criteria, endpoints, or results.SummaryDifference0.0%

Stay in the know with updates to Faricimab in Diabetic Macular Edema Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Faricimab in Diabetic Macular Edema Clinical Trial page.